Zheng Ding

Zhengzhou University

SCHOLARLY PAPERS

1

DOWNLOADS

10

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Preoperative Camrelizumab Combined with Chemotherapy for Borderline Resectable Esophageal Squamous Cell Carcinoma (BRES-1): A Single-Arm, Prospective, Phase 2 Study

Number of pages: 23 Posted: 19 Mar 2024
Zhengzhou University, Zhengzhou University, Zhengzhou University, Zhengzhou University, Zhengzhou University, Zhengzhou University, Zhengzhou University, Zhengzhou University, Zhengzhou University and Zhengzhou University
Downloads 10 (1,279,106)

Abstract:

Loading...

borderline resectable thoracic esophageal squamous cell carcinoma, esophagectomy, pathologic complete response.